These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 16804795

  • 1. Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study.
    Eschmann SM, Thelen MH, Dittmann H, Bares R.
    Exp Clin Endocrinol Diabetes; 2006 May; 114(5):222-6. PubMed ID: 16804795
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].
    Sabri O, Zimny M, Schreckenberger M, Reinartz P, Nowak B, Ostwald E, Schäfer W, Block S, Setani K, Büll U.
    Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M, Moka D, Reinholz U, Schmidt M, Schomäcker K, Schicha H, Wellner U.
    Nuklearmedizin; 2007 Feb; 46(3):77-84. PubMed ID: 17549318
    [Abstract] [Full Text] [Related]

  • 10. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L, Huot C, Lambert R, Deal C, Collu R, Van Vliet G.
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficiency analysis of using tailored individual doses of radioiodine and fine tuning using a low-dose antithyroid drug in the treatment of Graves' disease.
    Liu CJ, Dong YY, Wang YW, Wang KH, Zeng QY.
    Nucl Med Commun; 2011 Mar; 32(3):227-32. PubMed ID: 21191313
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of diffuse hyperthyroid goiter with radioiodine: influence of propylthiouracil pretreatment].
    Véliz J, Pineda G, Arancibia P, Wohllk N.
    Rev Med Chil; 2000 Jun; 128(6):609-12. PubMed ID: 11016059
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T.
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [Abstract] [Full Text] [Related]

  • 18. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S, Jaatinen P, Huhtala H, Luukkaala T, Oksala H, Salmi J.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [Abstract] [Full Text] [Related]

  • 19. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA, Christ-Crain M, Eckard B, Schindler C, Nitzsche EU, Müller-Brand J, Müller B.
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [Abstract] [Full Text] [Related]

  • 20. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
    Walter MA, Schindler C, Christ-Crain M, Müller-Brand J, Müller B.
    Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.